Company intelligence / Profile preview

Kenota Health

Kitchener, Ontario, Canadakenota.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Kenota Health has completed at least one clinical validation study comparing its point-of-care allergy testing system ("Kenota 1 System") to established laboratory methods. The results focused on usability by untrained operators and accuracy compared to the FDA-cleared Phadia ImmunoCAP System. The trial was completed and registered as NCT05702671. No therapeutic efficacy data applies since this is a diagnostic device.

Therapeutic areas: Immunology
Modalities: Device
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Kenota Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kenota Health.

Explore the full profile